User profiles for Julia Chalaye

julia chalaye

praticien hospitalier, hopital henri mondor
Verified email at hmn.aphp.fr
Cited by 1544

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular …

…, A Bouvier, L Vervueren, J Chalaye… - The Lancet …, 2017 - thelancet.com
Background Sorafenib is the recommended treatment for patients with advanced hepatocellular
carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective …

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01 …

E Garin, L Tselikas, B Guiu, J Chalaye… - The lancet …, 2021 - thelancet.com
Background All randomised phase 3 studies of selective internal radiation therapy for advanced
hepatocellular carcinoma published to date have reported negative results. However, …

Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma

J Chalaye, CE Costentin, A Luciani, G Amaddeo… - Journal of …, 2018 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) staging according to the Barcelona
Clinical Liver Cancer (BCLC) classification is based on conventional imaging. The aim of our …

[18F]-NaF PET/CT imaging in cardiac amyloidosis

…, E Evangelista, M Sasanelli, J Chalaye… - Journal of nuclear …, 2016 - Springer
Cardiac amyloidosis (CA) is recognized as a common cause of restrictive cardiomyopathy
and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We …

[HTML][HTML] 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: a prospective observational study

C Lim, C Salloum, J Chalaye, E Lahat, CE Costentin… - HPB, 2019 - Elsevier
Background This study assessed the prognostic value of 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET)/computed tomography (CT) in the prediction of MVI …

Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study …

E Garin, L Tzelikas, B Guiu, J Chalaye, J Edeline… - 2020 - ascopubs.org
516 Background: 90Y loaded microsphere SIRT (radioembolization) is a treatment option in
advanced HCC. However, no personalized dosimetric endpoints are currently used. The …

[HTML][HTML] Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)

…, J Darreon, JL Raoul, A Sarran, J Chalaye… - European Journal of …, 2021 - Elsevier
Background The aim of this ancillary study of the SARAH trial is to compare health-related
quality of life (HRQoL) in patients with locally advanced or inoperable hepatocellular …

Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable …

S Mulé, J Chalaye, F Legou, A Tenenhaus… - European …, 2020 - Springer
Objectives To compare the performance of the quantitative analysis of the hepatobiliary phase
(HBP) tumor enhancement in gadobenate dimeglumine (Gd-BOPTA)–enhanced MRI and …

Hepatocellular carcinomas with mutational activation of beta-catenin require choline and can be detected by positron emission tomography

…, D Wendum, JN Talbot, A Prignon, J Chalaye… - Gastroenterology, 2019 - Elsevier
Background & Aims In one-third of hepatocellular carcinomas (HCCs), cancer cells have
mutations that activate β-catenin pathway. These cells have alterations in glutamine, bile, and …

Chest PET/MRI in Solid Cancers: Comparing the Diagnostic Performance of a Free‐Breathing 3D‐T1‐GRE Stack‐of‐Stars Volume Interpolated Breath‐Hold …

…, B Emsen, A Monnet, J Chalaye… - Journal of Magnetic …, 2022 - Wiley Online Library
Background Whole‐body positron emission tomography/magnetic resonance imaging (WB‐PET/MRI)
is increasingly used in oncology. However, chest staging remains challenging. …